Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis

Gastrointestinal Endoscopy

Volumn 70, Issue 2, 2009, Pages 246-253

  Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Arisawa, Tomiyasu ^a   Hirata, Ichiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; BLOOD VESSEL; CLINICAL TRIAL; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NARROW BAND IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; STOMACH ATROPHY; STOMACH DISEASE; STOMACH MUCOSA; UPPER GASTROINTESTINAL TRACT;

AGED; CAPILLARIES; CHRONIC DISEASE; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 67651121768     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2008.11.046     Document Type: Article

References (23)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272 (1994) 65-69
2. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
3. Parsonnet J., Friedman G.D., Vandersteen D.P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325 (1991) 1127-1131
4. Huang J.Q., Sridhar S., Chen Y., et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114 (1998) 1169-1179
5. Blaser M.J., and Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 94 (1994) 4-8
6. Gono K., Obi T., Yamaguchi M., et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt 9 (2004) 568-577
7. Goda K., Tajiri H., Ikegami M., et al. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma. Gastrointest Endosc 65 (2007) 36-46
8. Sharma P., Bansal A., Mathur S., et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc 64 (2006) 167-175
9. Shibuya K., Hoshino H., Chiyo M., et al. High magnification bronchovideoscopy combined with narrow band imaging could detect capillary loops of angiogenic squamous dysplasia in heavy smokers at high risk for lung cancer. Thorax 58 (2003) 989-995
10. Machida H., Sano Y., Hamamoto Y., et al. Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study. Endoscopy 36 (2004) 1094-1098
11. Bansai A., Ozlen U., Shard M., et al. Correlation between narrow band imaging and nonneoplastic gastric pathology: a pilot feasibility trial. Gastrointest Endosc 67 (2008) 210-216
12. Kekki M., Samloff I.M., Varis K., et al. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 186 suppl (1991) 109-116
13. Asaka M., Kimura T., Kudo M., et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102 (1992) 760-766
14. Kimura K., and Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 5 (1973) 21-26
15. Yagi K., Nakamura A., and Sekine A. Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylori infection. J Gastroenterol Hepatol 17 (2002) 39-45
16. Anagnostopoulos G.K., Yao K., Kaye P., et al. High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy 39 (2007) 202-207
17. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20 (1996) 1161-1181
18. Dinis-Ribeiro M., Yamaki G., Miki K., et al. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 11 (2004) 141-147
19. Sakaki N., Iida Y., Okazaki Y., et al. Magnifying endoscopic observation of the gastric mucosa, particularly in patients with atrophic gastritis. Endoscopy 10 (1978) 269-274
20. Kokkola A., Kosunen T.U., Puolakkainen P., et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 111 (2003) 619-624
21. Uemura N., Mukai T., Okamoto S., et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 639-642
22. Wong B.C., Lam S.K., Wong W.M., et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291 (2004) 187-194
23. Hosokawa O., Tsuda S., Kidani E., et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 30 (1998) 721-773